Sign In
Buy BDX
$145.61
+1.18 (+0.82%)
At Close: Jun 03, 2026
Becton Dickinson (BDX) Reports Q2 Earnings: What Key Metrics Have to Say
10:36am, Thursday, 01'st May 2025
Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall
Cramer's Stop Trading: Becton Dickinson
10:22am, Thursday, 01'st May 2025
CNBC's Jim Cramer explains why he is keeping an eye on shares of Becton Dickinson.
Becton Dickinson (BDX) Q2 Earnings Top Estimates
08:45am, Thursday, 01'st May 2025
Becton Dickinson (BDX) came out with quarterly earnings of $3.35 per share, beating the Zacks Consensus Estimate of $3.28 per share. This compares to earnings of $3.17 per share a year ago.
Medical device maker Becton Dickinson cuts 2025 profit forecast on potential tariff hit
07:48am, Thursday, 01'st May 2025
Medical device maker Becton Dickinson lowered its annual profit forecast on Thursday, in anticipation of a potential hit from U.S. President Donald Trump's tariffs, sending its shares down 5% in prema
BD Reports Second Quarter Fiscal 2025 Financial Results
06:30am, Thursday, 01'st May 2025
Revenue of $5.3 billion increased 4.5% as reported, 6.0% currency-neutral and 0.9% organic GAAP and adjusted diluted EPS of $1.07 and $3.35, respectively Company updates full-year fiscal 2025 guidance
BD to Present at Bank of America Securities Health Care Conference
04:15pm, Wednesday, 30'th Apr 2025
FRANKLIN LAKES, N.J. , April 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of A
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK
11:55am, Wednesday, 30'th Apr 2025
This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues.
Best Dividend Aristocrats For May 2025
08:07pm, Tuesday, 29'th Apr 2025
Despite a strong start, the Dividend Aristocrats are underperforming the S&P 500 in April, with NOBL down 4.88% and SPY down 1.53%. The best-performing Dividend Aristocrats YTD include Consolidated Ed
BD Board Declares Dividend
04:20pm, Tuesday, 29'th Apr 2025
FRANKLIN LAKES, N.J. , April 29, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has dec
Can Sustained Product Demand Drive BDX Stock Before Q2 Earnings?
01:20pm, Monday, 28'th Apr 2025
The continued solid uptake of BD's products is expected to have driven fiscal second-quarter revenues despite transitory market dynamics.
Gear Up for Becton Dickinson (BDX) Q2 Earnings: Wall Street Estimates for Key Metrics
10:21am, Monday, 28'th Apr 2025
Besides Wall Street's top -and-bottom-line estimates for Becton Dickinson (BDX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared durin
Becton, Dickinson and Company: It's Wait And See For Me
01:17am, Sunday, 27'th Apr 2025
Becton, Dickinson and Company is a leading medical device firm specializing in medical supplies, devices, laboratory equipment, and diagnostic products. BDX operates in three segments: BD Medical, BD
2025 Dividend Kings: Weathering Tariff Volatility Better Than The Market
09:58am, Wednesday, 23'rd Apr 2025
The Dividend Kings are outperforming the S&P 500 in 2025 by 8.94%. Top performers include National Fuel & Gas (+28.88%), Consolidated Edison (+28.10%), and Middlesex Water Company (+21.00%). Promising
BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair
06:50am, Wednesday, 23'rd Apr 2025
Phasix™ ST Umbilical Hernia Patch Leverages Same Surgical Technique as Permanent Mesh Procedures FRANKLIN LAKES, N.J. , April 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BD
BD Stock Down Despite Monitoring Platform Launch to Boost Patient Care
12:30pm, Tuesday, 22'nd Apr 2025
BDX's AI-based advanced hemodynamic monitoring platform is likely to aid clinicians to address blood flow instability and pressure in critical situations and improve patient outcomes.
